UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
FDA OKs Huons' generic of topic anesthetic injection
by Lee Han-soo
2020-01-02 14:30
Medytox launches liquid-type BTX 'Innotox 100 unit' in local market
by Lee Han-soo
2020-01-02 12:12
Medical info kiosk lends a helping hand for foreign patients
by Lee Han-soo
2020-01-01 05:27
MSD’s monitoring causes stir for alleged violation of physicians’ privacies
by Kim Yun-mi
2019-12-31 12:40
Allergan shrouded in controversy for rare cancer-causing breast implants
by Park Gi-taek
2019-12-31 10:20
라인
Korea Biomedical Review’s ‘Top 20’ news
by Lee Han-soo
2019-12-31 10:17
Korean biopharmaceuticals competitively move abroad to expand global presence
by Jeong Sae-im
2019-12-30 17:20
Industry welcomes legislation of advanced regenerative bio act
by Park Gi-taek
2019-12-30 11:56
Shanghai Ocumension to market Huonland's HA eyedrop
by Lee Han-soo
2019-12-23 15:43
Alteogen's growth hormone deficiency treatment wins orphan drug status
by Lee Han-soo
2019-12-23 14:46
라인
Daewoong partners with Aeon Biopharma to tap therapeutic BTX market
by Lee Han-soo
2019-12-23 11:23
SNUBH teaches cerebrovascular surgery tech to Thai hospital
by Lee Han-soo
2019-12-20 17:37
‘Depressed cancer patients have higher risk of death’
by Lee Han-soo
2019-12-20 16:30
Successful drug development – getting it right from the start
by Lee Han-soo
2019-12-20 16:30
Samsung Bioepis’ Ontruzant 1st biosimilar to win WHO's PQ certification
by Lee Han-soo
2019-12-20 16:29
라인
Chemas to research anticancer treatment in Germany
by Lee Han-soo
2019-12-20 15:18
Bridge Biotherapeutics seeks IND status for lung cancer treatment
by Lee Han-soo
2019-12-20 14:41
Boehringer Ingelheim stops developing Pharmaxis’ NASH treatment candidate
by Lee Han-soo
2019-12-19 17:42
AstraZeneca, Korean partners launch joint project to accelerate bio-health innovation
by Lee Han-soo
2019-12-19 17:40
AstraZeneca, SK Holdings celebrates manufacturing partnership
by Lee Han-soo
2019-12-19 16:39
-
이전
21
22
23
24
25
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top